Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Evaluation of molecular species of prostate-specific antigen complexed with immunoglobulin M in prostate cancer and benign prostatic hyperplasia.

Goč S, Janković M.

Dis Markers. 2013;35(6):847-55. doi: 10.1155/2013/923819. Epub 2013 Dec 3.

PMID:
24367138
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.

Beneduce L, Prayer-Galetti T, Giustinian AM, Gallotta A, Betto G, Pagano F, Fassina G.

Cancer Detect Prev. 2007;31(5):402-7. Epub 2007 Nov 26.

PMID:
18035503
[PubMed - indexed for MEDLINE]
3.

On chip immuno-affinity profiling of cancer- and benign hyperplasia-associated free prostate specific antigen.

Kosanovic MM, Goc SR, Potpara GS, Jankovic MM.

Dis Markers. 2011;31(2):111-8. doi: 10.3233/DMA-2011-0809.

PMID:
21897005
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.

Kwiatkowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, Tscholl R.

Urology. 1998 Sep;52(3):360-5.

PMID:
9730444
[PubMed - indexed for MEDLINE]
5.

Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia.

Charrier JP, Tournel C, Michel S, Dalbon P, Jolivet M.

Electrophoresis. 1999 Apr-May;20(4-5):1075-81.

PMID:
10344287
[PubMed - indexed for MEDLINE]
6.

Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors.

Hilz H, Noldus J, Hammerer P, Buck F, Lück M, Huland H.

Eur Urol. 1999 Oct;36(4):286-92.

PMID:
10473986
[PubMed - indexed for MEDLINE]
7.

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.

Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.

Cancer. 1998 Dec 15;83(12):2540-7.

PMID:
9874461
[PubMed - indexed for MEDLINE]
8.

Glycan characterization of PSA 2-DE subforms from serum and seminal plasma.

Sarrats A, Saldova R, Comet J, O'Donoghue N, de Llorens R, Rudd PM, Peracaula R.

OMICS. 2010 Aug;14(4):465-74. doi: 10.1089/omi.2010.0050.

PMID:
20726802
[PubMed - indexed for MEDLINE]
9.

Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.

Jung K, Brux B, Lein M, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA, Sinha P.

Clin Chem. 2000 Jan;46(1):47-54.

PMID:
10620571
[PubMed - indexed for MEDLINE]
Free Article
10.

Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer.

Zhang WM, Finne P, Leinonen J, Salo J, Stenman UH.

Urology. 2000 Aug 1;56(2):267-72.

PMID:
10925092
[PubMed - indexed for MEDLINE]
11.

[Immunity and cancer: the role of PSA IgM Immune complexes for prostate cancer].

Zani D, Costa S, Beneduce L, Fassina G, Simeone C, Cosciani Cunico S.

Urologia. 2010 Jan-Mar;77(1):1-3. Italian.

PMID:
20890851
[PubMed - indexed for MEDLINE]
12.

Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.

Tabarés G, Radcliffe CM, Barrabés S, Ramírez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R.

Glycobiology. 2006 Feb;16(2):132-45. Epub 2005 Sep 21.

PMID:
16177264
[PubMed - indexed for MEDLINE]
Free Article
13.

Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.

Janković MM, Kosanović MM.

Clin Biochem. 2005 Jan;38(1):58-65.

PMID:
15607318
[PubMed - indexed for MEDLINE]
14.

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Haese A, Graefen M, Steuber T, Becker C, Noldus J, Erbersdobler A, Huland E, Huland H, Lilja H.

J Urol. 2003 Dec;170(6 Pt 1):2269-73.

PMID:
14634394
[PubMed - indexed for MEDLINE]
15.

Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.

Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL.

Clin Chem. 1993 Dec;39(12):2483-91.

PMID:
7504592
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.

Froehner M, Hakenberg OW, Koch R, Schmidt U, Meye A, Wirth MP.

Urol Int. 2006;76(1):27-30.

PMID:
16401917
[PubMed - indexed for MEDLINE]
18.

Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?

Jung K, Elgeti U, Lein M, Brux B, Sinha P, Rudolph B, Hauptmann S, Schnorr D, Loening SA.

Clin Chem. 2000 Jan;46(1):55-62.

PMID:
10620572
[PubMed - indexed for MEDLINE]
Free Article
19.

Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.

Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H.

J Urol. 1997 Dec;158(6):2188-92.

PMID:
9366341
[PubMed - indexed for MEDLINE]
20.

Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.

Jung K, Brux B, Lein M, Knäbich A, Sinha P, Rudolph B, Schnorr D, Loening SA.

Urology. 1999 Jun;53(6):1160-7; discussion 1167-8.

PMID:
10367846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk